The experiment demonstrated the essential role of TGF‐β/Smad2/3 signaling pathway in vascular remodeling and revealed that inhibition of vascular remodeling may become a new therapeutic strategy to inhibit the progression of hypertensive diseases.64 The gene discussed is SMAD2; the disease is hypertensive disorder.